B. Riley analyst Bryce Rowe lowered the firm’s price target on Oaktree Specialty Lending (OCSL) to $15 from $17 and keeps a Neutral rating on the shares post the fiscal Q3 report. The stock’s current price to net asset value of 86% is appropriate until NAV compression halts and a path to dividend coverage without fee waivers emerges, the analyst tells investors in a research note.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCSL:
- Oaktree Specialty Lending downgraded to Neutral from Overweight at JPMorgan
- Oaktree Specialty Lending Q4 2024 Earnings Overview
- Keefe lowers Oaktree Specialty target, says dividend at risk
- Oaktree Specialty Lending downgraded at JMP with fundamentals yet to stabilize
- Oaktree Specialty Lending downgraded to Market Perform at JMP Securities